Zymeworks is Xencor's top competitor. Zymeworks is a Public company that was founded in Vancouver, British Columbia in 2003. Zymeworks operates in the Biotechnology industry. Zymeworks has 3 fewer employees vs. Xencor.
Xencor VS Merus
Merus has been one of Xencor's top competitors. Merus is headquartered in Utrecht, Utrecht, and was founded in 2003. Merus is in the Biotechnology field. Merus generates 32% the revenue of Xencor.
Xencor VS MacroGenics
MacroGenics is perceived as one of Xencor's biggest rivals. MacroGenics was founded in 2000 in Rockville, Maryland. MacroGenics competes in the Biotechnology field. MacroGenics generates $39.5M more revenue than Xencor.
Six posters highlight continued progress across antibody-drug conjugate and T cell engager platformsNovel T cell engager ZW209 demonstrates durable act...
(RTTNews) - PTC Therapeutics, Inc. (PTCT) Friday said that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (...
- Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC interim clinical data selected for poster presentation - Conference call on Thu...
Fujifilm Diosynth Biotechnologies, a world─leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced the...
Amgen is the latest in a series of biopharma companies to announce a massive new US-based investment in manufacturing in response to the Trump administ...
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. ("Sarepta" or t...
AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO PR Newswire THOUSAND OAKS, Calif., April 25, 2025 Total Investme...
Global nephrology drugs market is estimated to be valued at USD 18.37 Bn in 2025 and is expected to reach USD 29.14 Bn by 2032, exhibiting a compound a...
Fujifilm Diosynth Biotechnologies, a major contract development and manufacturing organization (CDMO), has entered into a 10-year manufacturing supply ...
The Global Multiple Myeloma Market reached USD 20.2 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 31.3 billion by ...
Frequently Asked Questions about Xencor
Who are Xencor's top competitors?
Xencor's top 3 competitors are Zymeworks, Merus, MacroGenics.
Who is similar to Xencor?
Zymeworks is the most similar to Xencor. Merus and MacroGenics are also similar to Xencor.
Are Xencor and Zymeworks competitors?
Yes, Zymeworks is one of Xencor’s top competitors.